Literature DB >> 27221798

[Comorbidity in psoriasis].

S Gerdes1, U Mrowietz2, W-H Boehncke3.   

Abstract

Psoriasis is a systemic chronic inflammatory disease associated with comorbidity. Many epidemiological studies have shown that psoriasis is associated with psoriatic arthritis as well as cardiovascular and metabolic diseases. Furthermore, obesity and psychological diseases such as depression and anxiety disorders are linked with psoriasis and play a central role in its management. The association of psoriasis and its comorbidity can be partly explained by genetic and pathophysiological mechanisms. Approximately 40 psoriasis susceptibility loci have been described with the majority linked to the innate and adaptive immune system. In some associated diseases, such as psoriatic arthritis, an overlap of their genetic susceptibility exists. Pathophysiologically the "psoriatic march" is a model that describes the development of metabolic and cardiovascular diseases due to the presence of underlying systemic inflammation. Dermatologists are the gatekeepers to treatment for patients with psoriasis. The early detection and the management of comorbidity is part of their responsibility. Concepts for the management of psoriasis and tools to screen for psoriatic comorbidity have been developed in order to support dermatologists in daily practice.

Entities:  

Keywords:  Depression; Genetics; Inflammation; Obesity; Psoriatic arthritis

Mesh:

Substances:

Year:  2016        PMID: 27221798     DOI: 10.1007/s00105-016-3805-3

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  24 in total

Review 1.  Obesity and psoriasis: body weight and body mass index influence the response to biological treatment.

Authors:  L Puig
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-04-15       Impact factor: 6.166

2.  The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.

Authors:  Wolf-Henning Boehncke; Sandra Boehncke; Anne-Marie Tobin; Brian Kirby
Journal:  Exp Dermatol       Date:  2011-04       Impact factor: 3.960

Review 3.  Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis.

Authors:  Axel Patrice Villani; Marie Rouzaud; Morgane Sevrain; Thomas Barnetche; Carle Paul; Marie-Aleth Richard; Marie Beylot-Barry; Laurent Misery; Pascal Joly; Michel Le Maitre; Selim Aractingi; François Aubin; Alain Cantagrel; Jean-Paul Ortonne; Denis Jullien
Journal:  J Am Acad Dermatol       Date:  2015-06-06       Impact factor: 11.527

Review 4.  The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.

Authors:  Emmilia A Dowlatshahi; Marlies Wakkee; Lidia R Arends; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2013-11-27       Impact factor: 8.551

Review 5.  Psoriasis: to treat or to manage?

Authors:  Ulrich Mrowietz; Kirsten Steinz; Sascha Gerdes
Journal:  Exp Dermatol       Date:  2014-08-02       Impact factor: 3.960

Review 6.  Recommendations for detection of individual risk for comorbidities in patients with psoriasis.

Authors:  Johannes Wohlrab; Gabriele Fiedler; Sascha Gerdes; Alexander Nast; Sandra Philipp; Marc A Radtke; Diamant Thaçi; Wolfgang Koenig; Andreas F H Pfeiffer; Martin Härter; Michael P Schön
Journal:  Arch Dermatol Res       Date:  2013-02-03       Impact factor: 3.017

Review 7.  Psoriasis strikes back! Epicardial adipose tissue: another contributor to the higher cardiovascular risk in psoriasis.

Authors:  Inês Raposo; Tiago Torres
Journal:  Rev Port Cardiol       Date:  2015-09-26       Impact factor: 1.374

Review 8.  Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.

Authors:  April W Armstrong; Caitlin T Harskamp; Ehrin J Armstrong
Journal:  J Am Acad Dermatol       Date:  2013-01-27       Impact factor: 11.527

Review 9.  From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.

Authors:  Jeremy Hugh; Abby S Van Voorhees; Rajiv I Nijhawan; Jerry Bagel; Mark Lebwohl; Andrew Blauvelt; Sylvia Hsu; Jeffrey M Weinberg
Journal:  J Am Acad Dermatol       Date:  2013-11-01       Impact factor: 11.527

10.  Comparative genomic profiling of synovium versus skin lesions in psoriatic arthritis.

Authors:  Jennifer Belasco; James S Louie; Nicholas Gulati; Nathan Wei; Kristine Nograles; Judilyn Fuentes-Duculan; Hiroshi Mitsui; Mayte Suárez-Fariñas; James G Krueger
Journal:  Arthritis Rheumatol       Date:  2015-04       Impact factor: 10.995

View more
  7 in total

1.  [Insufficient tetanus vaccination protection in psoriasis and systemic immunosuppression : Results of a retrospective investigation of 101 patients].

Authors:  W Sondermann; L Leister; N Rompoti; J Dissemond; J Klode; A Körber
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

2.  [Psoriasis].

Authors:  R Sabat; M P Schön; K Schäkel
Journal:  Hautarzt       Date:  2016-06       Impact factor: 0.751

Review 3.  Impact of Chronic Inflammation in Psoriasis on Bone Metabolism.

Authors:  Anja Saalbach; Manfred Kunz
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

4.  Lipid profile disturbances may predispose psoriatic patients to liver dysfunction.

Authors:  Dorota Kozłowska; Ewa Harasim-Symbor; Hanna Myśliwiec; Anna J Milewska; Adrian Chabowski; Iwona Flisiak
Journal:  Postepy Dermatol Alergol       Date:  2021-05-22       Impact factor: 1.837

Review 5.  Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis.

Authors:  Angel Yun-Kuan Thye; Yi-Rou Bah; Jodi Woan-Fei Law; Loh Teng-Hern Tan; Ya-Wen He; Sunny-Hei Wong; Sivakumar Thurairajasingam; Kok-Gan Chan; Learn-Han Lee; Vengadesh Letchumanan
Journal:  Biomedicines       Date:  2022-04-30

Review 6.  Psoriasis: Obesity and Fatty Acids.

Authors:  Manfred Kunz; Jan C Simon; Anja Saalbach
Journal:  Front Immunol       Date:  2019-07-31       Impact factor: 7.561

7.  Skin Diseases in Patients with Primary Psychiatric Disorders.

Authors:  Paraskevi Mavrogiorgou; Corinna Mersmann; Gabriele Gerlach; Stephan Herpertz; Georg Juckel
Journal:  Psychiatry Investig       Date:  2020-02-25       Impact factor: 2.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.